Table 1.
Clinical characteristics of the symptomatic ARVD-C patients
| Parameters | Value |
|---|---|
| Study population | 20 patients |
| Age (years) | 43±15.4 (min 21, max 72) |
| Male (gender) | 8 (40%) |
| Definite diagnosis | 16 (80%) |
| Borderline diagnosis | 4 (20%) |
| Electrocardiography findings | |
| Epsilon waves in V1 - V3 | 2 (10%) |
| TAD of QRS ≥55 ms | 2 (10%) |
| Inverted T-waves in right | 5 (25%) |
| precordial leads (V1, V2, and V3) | |
| Non-sustained VT | 13 (65%) |
| Sustained VT | 4 (20%) |
| Echocardiography | |
| RV aneurysm, akinesia, dyskinesia | 15 (75%) |
| PALX RVOT ≥32 mm | 9 (45%) |
| PSAX RVOT ≥36 mm | 14 (70%) |
| Fractional area change ≤33% | 0 |
| 24-hour Holter monitoring | |
| Ventricular extrasystoles in 24h≥500 | 13 (65%) |
| Cardiac magnetic resonance | |
| Structural changes | 6 (30%) |
| RVEDV/BSA >100 mL/m2 | 1 (5%) |
| RV EF <45% | 3 (15%) |
| Therapy | |
| Beta blockers | 9 (45%) |
| RFCA | 7 (35%) |
| ICD | 3 (15%) |
| Sudden cardiac death risk | |
| High risk | 4 (20%) |
| Moderate risk | 13 (65%) |
| Low risk | 3 (15%) |